Skip to main content
Erschienen in:

28.07.2017 | ORIGINAL ARTICLE

Endothelial BMP4 Regulates Leukocyte Diapedesis and Promotes Inflammation

verfasst von: Thomas Helbing, Linus Arnold, Gwendoline Wiltgen, Eva Hirschbihl, Valentin Gabelmann, Alexandra Hornstein, Jennifer S. Esser, Philipp Diehl, Sebastian Grundmann, Hans-Jörg Busch, Katrin Fink, Christoph Bode, Martin Moser

Erschienen in: Inflammation | Ausgabe 6/2017

Einloggen, um Zugang zu erhalten

Abstract

Leukocyte recruitment is a fundamental event in the response of the innate immune system to injury. This process is promoted in part by the opening of endothelial cell adherens junctions that allows leukocyte extravasation through gaps between adjacent endothelial cells. VE-cadherin is a key component of endothelial cell adherens junctions and a negative regulator of leukocyte emigration. Accumulating evidence implicates bone morphogenetic protein (BMP) 4 as a critical regulator in vascular biology, but its role in leukocyte extravasation in vitro and in vivo has not been investigated so far. To assess the impact of BMP4 on leukocyte emigration in vivo, we used the thioglycollate-induced peritonitis model. C57BL/6 mice were intraperitoneally (i.p.) injected with recombinant BMP4 in addition to thioglycollate. Compared to solvent-treated controls, we observed higher accumulation of leukocytes in the peritoneal lavage of BMP4-treated mice indicating that BMP4 promotes leukocyte diapedesis into the inflamed peritoneal cavity. Endothelial cell-specific deletion of BMP4 in mice markedly diminished leukocyte diapedesis following thioglycollate administration suggesting that endothelial BMP4 is required for leukocyte recruitment. Consistent with these in vivo results, transwell migration assays with human umbilical vein endothelial cells (HUVECs) in vitro revealed that recombinant BMP4 enhanced leukocyte transmigration through the endothelial monolayer. Conversely, silencing of endothelial BMP4 by siRNA dampened leukocyte diapedesis in vitro. Mechanistic studies showed that loss of BMP4 improved endothelial junction stability by upregulation of VE-cadherin expression in vitro and in vivo. Vice versa, treatment of HUVECs with recombinant BMP4 decreased expression of VE-cadherin and impaired endothelial junction stability shown by Western blotting and immunocytochemistry. Finally, severe endothelial damage in HUVECs in response to serum of patients collected 24 h after survived cardiac arrest was accompanied by increase in leukocyte migration in transwell assays and activation of the BMP pathway most probably by upregulation of endothelial BMP4 RNA and protein expression. Collectively, the present study provides novel evidence that endothelial BMP4 controls leukocyte recruitment through a VE-cadherin-dependent mechanism and that BMP4-induced inflammation might be involved in the pathogenesis of endothelial cell damage following successful resuscitation after cardiac arrest.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Sorescu, G.P., et al. 2003. Bone morphogenic protein 4 produced in endothelial cells by oscillatory shear stress stimulates an inflammatory response. The Journal of Biological Chemistry 278 (33): 31128–31135.CrossRefPubMed Sorescu, G.P., et al. 2003. Bone morphogenic protein 4 produced in endothelial cells by oscillatory shear stress stimulates an inflammatory response. The Journal of Biological Chemistry 278 (33): 31128–31135.CrossRefPubMed
2.
Zurück zum Zitat Rao, R.M., et al. 2007. Endothelial-dependent mechanisms of leukocyte recruitment to the vascular wall. Circulation Research 101 (3): 234–247.CrossRefPubMed Rao, R.M., et al. 2007. Endothelial-dependent mechanisms of leukocyte recruitment to the vascular wall. Circulation Research 101 (3): 234–247.CrossRefPubMed
3.
Zurück zum Zitat Helbing, T., G. Wiltgen, A. Hornstein, E.Z. Brauers, L. A. Arnold, et al. 2017. Bone morphogenetic protein-modulator BMPER regulates endothelial barrier function. Inflammation 40 (2): 442–453. doi:10.1007/s10753-016-0490-4. Helbing, T., G. Wiltgen, A. Hornstein, E.Z. Brauers, L. A. Arnold, et al. 2017. Bone morphogenetic protein-modulator BMPER regulates endothelial barrier function. Inflammation 40 (2): 442–453. doi:10.​1007/​s10753-016-0490-4.
4.
Zurück zum Zitat Schulte, D., et al. 2011. Stabilizing the VE-cadherin-catenin complex blocks leukocyte extravasation and vascular permeability. The EMBO Journal 30 (20): 4157–4170.CrossRefPubMedPubMedCentral Schulte, D., et al. 2011. Stabilizing the VE-cadherin-catenin complex blocks leukocyte extravasation and vascular permeability. The EMBO Journal 30 (20): 4157–4170.CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Vestweber, D. 2008. VE-cadherin: The major endothelial adhesion molecule controlling cellular junctions and blood vessel formation. Arteriosclerosis, Thrombosis, and Vascular Biology 28 (2): 223–232.CrossRefPubMed Vestweber, D. 2008. VE-cadherin: The major endothelial adhesion molecule controlling cellular junctions and blood vessel formation. Arteriosclerosis, Thrombosis, and Vascular Biology 28 (2): 223–232.CrossRefPubMed
6.
Zurück zum Zitat Vestweber, D., et al. 2009. Cell adhesion dynamics at endothelial junctions: VE-cadherin as a major player. Trends in Cell Biology 19 (1): 8–15.CrossRefPubMed Vestweber, D., et al. 2009. Cell adhesion dynamics at endothelial junctions: VE-cadherin as a major player. Trends in Cell Biology 19 (1): 8–15.CrossRefPubMed
7.
Zurück zum Zitat Gotsch, U., et al. 1997. VE-cadherin antibody accelerates neutrophil recruitment in vivo. Journal of Cell Science 110 (Pt 5): 583–588.PubMed Gotsch, U., et al. 1997. VE-cadherin antibody accelerates neutrophil recruitment in vivo. Journal of Cell Science 110 (Pt 5): 583–588.PubMed
8.
Zurück zum Zitat Giannotta, M., M. Trani, and E. Dejana. 2013. VE-cadherin and endothelial adherens junctions: Active guardians of vascular integrity. Developmental Cell 26 (5): 441–454.CrossRefPubMed Giannotta, M., M. Trani, and E. Dejana. 2013. VE-cadherin and endothelial adherens junctions: Active guardians of vascular integrity. Developmental Cell 26 (5): 441–454.CrossRefPubMed
9.
Zurück zum Zitat Broermann, A., et al. 2011. Dissociation of VE-PTP from VE-cadherin is required for leukocyte extravasation and for VEGF-induced vascular permeability in vivo. The Journal of Experimental Medicine 208 (12): 2393–2401.CrossRefPubMedPubMedCentral Broermann, A., et al. 2011. Dissociation of VE-PTP from VE-cadherin is required for leukocyte extravasation and for VEGF-induced vascular permeability in vivo. The Journal of Experimental Medicine 208 (12): 2393–2401.CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Lampugnani, M.G., et al. 2002. VE-cadherin regulates endothelial actin activating Rac and increasing membrane association of Tiam. Molecular Biology of the Cell 13 (4): 1175–1189.CrossRefPubMedPubMedCentral Lampugnani, M.G., et al. 2002. VE-cadherin regulates endothelial actin activating Rac and increasing membrane association of Tiam. Molecular Biology of the Cell 13 (4): 1175–1189.CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Cai, J., et al. 2012. BMP signaling in vascular diseases. FEBS Letters 586 (14): 1993–2002.CrossRefPubMed Cai, J., et al. 2012. BMP signaling in vascular diseases. FEBS Letters 586 (14): 1993–2002.CrossRefPubMed
12.
Zurück zum Zitat Dyer, L.A., X. Pi, and C. Patterson. 2014. The role of BMPs in endothelial cell function and dysfunction. Trends in Endocrinology and Metabolism 25 (9): 472–480.CrossRefPubMedPubMedCentral Dyer, L.A., X. Pi, and C. Patterson. 2014. The role of BMPs in endothelial cell function and dysfunction. Trends in Endocrinology and Metabolism 25 (9): 472–480.CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Garcia de Vinuesa, A., et al. 2016. BMP signaling in vascular biology and dysfunction. Cytokine & Growth Factor Reviews 27: 65–79.CrossRef Garcia de Vinuesa, A., et al. 2016. BMP signaling in vascular biology and dysfunction. Cytokine & Growth Factor Reviews 27: 65–79.CrossRef
14.
Zurück zum Zitat Pardali, E., and P. Ten Dijke. 2012. TGFbeta signaling and cardiovascular diseases. International Journal of Biological Sciences 8 (2): 195–213.CrossRefPubMedPubMedCentral Pardali, E., and P. Ten Dijke. 2012. TGFbeta signaling and cardiovascular diseases. International Journal of Biological Sciences 8 (2): 195–213.CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Wagner, D.O., et al. 2010. BMPs: From bone to body morphogenetic proteins. Science Signaling 3 (107): mr1.PubMed Wagner, D.O., et al. 2010. BMPs: From bone to body morphogenetic proteins. Science Signaling 3 (107): mr1.PubMed
16.
Zurück zum Zitat Koga, M., et al. 2013. The bone morphogenic protein inhibitor, noggin, reduces glycemia and vascular inflammation in db/db mice. American Journal of Physiology. Heart and Circulatory Physiology 305 (5): H747–H755.CrossRefPubMedPubMedCentral Koga, M., et al. 2013. The bone morphogenic protein inhibitor, noggin, reduces glycemia and vascular inflammation in db/db mice. American Journal of Physiology. Heart and Circulatory Physiology 305 (5): H747–H755.CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Miriyala, S., et al. 2006. Bone morphogenic protein-4 induces hypertension in mice: Role of noggin, vascular NADPH oxidases, and impaired vasorelaxation. Circulation 113 (24): 2818–2825.CrossRefPubMed Miriyala, S., et al. 2006. Bone morphogenic protein-4 induces hypertension in mice: Role of noggin, vascular NADPH oxidases, and impaired vasorelaxation. Circulation 113 (24): 2818–2825.CrossRefPubMed
18.
Zurück zum Zitat Sorescu, G.P., et al. 2004. Bone morphogenic protein 4 produced in endothelial cells by oscillatory shear stress induces monocyte adhesion by stimulating reactive oxygen species production from a nox1-based NADPH oxidase. Circulation Research 95 (8): 773–779.CrossRefPubMed Sorescu, G.P., et al. 2004. Bone morphogenic protein 4 produced in endothelial cells by oscillatory shear stress induces monocyte adhesion by stimulating reactive oxygen species production from a nox1-based NADPH oxidase. Circulation Research 95 (8): 773–779.CrossRefPubMed
19.
Zurück zum Zitat Chang, K., et al. 2007. Bone morphogenic protein antagonists are coexpressed with bone morphogenic protein 4 in endothelial cells exposed to unstable flow in vitro in mouse aortas and in human coronary arteries: Role of bone morphogenic protein antagonists in inflammation and atherosclerosis. Circulation 116 (11): 1258–1266.CrossRefPubMed Chang, K., et al. 2007. Bone morphogenic protein antagonists are coexpressed with bone morphogenic protein 4 in endothelial cells exposed to unstable flow in vitro in mouse aortas and in human coronary arteries: Role of bone morphogenic protein antagonists in inflammation and atherosclerosis. Circulation 116 (11): 1258–1266.CrossRefPubMed
20.
Zurück zum Zitat Csiszar, A., et al. 2008. Differential proinflammatory and prooxidant effects of bone morphogenetic protein-4 in coronary and pulmonary arterial endothelial cells. American Journal of Physiology. Heart and Circulatory Physiology 295 (2): H569–H577.CrossRefPubMedPubMedCentral Csiszar, A., et al. 2008. Differential proinflammatory and prooxidant effects of bone morphogenetic protein-4 in coronary and pulmonary arterial endothelial cells. American Journal of Physiology. Heart and Circulatory Physiology 295 (2): H569–H577.CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Csiszar, A., et al. 2007. Downregulation of bone morphogenetic protein 4 expression in coronary arterial endothelial cells: Role of shear stress and the cAMP/protein kinase A pathway. Arteriosclerosis, Thrombosis, and Vascular Biology 27 (4): 776–782.CrossRefPubMed Csiszar, A., et al. 2007. Downregulation of bone morphogenetic protein 4 expression in coronary arterial endothelial cells: Role of shear stress and the cAMP/protein kinase A pathway. Arteriosclerosis, Thrombosis, and Vascular Biology 27 (4): 776–782.CrossRefPubMed
22.
Zurück zum Zitat Jo, H., H. Song, and A. Mowbray. 2006. Role of NADPH oxidases in disturbed flow- and BMP4-induced inflammation and atherosclerosis. Antioxidants & Redox Signaling 8 (9–10): 1609–1619.CrossRef Jo, H., H. Song, and A. Mowbray. 2006. Role of NADPH oxidases in disturbed flow- and BMP4-induced inflammation and atherosclerosis. Antioxidants & Redox Signaling 8 (9–10): 1609–1619.CrossRef
23.
Zurück zum Zitat Corriere, M.A., et al. 2008. Endothelial Bmp4 is induced during arterial remodeling: Effects on smooth muscle cell migration and proliferation. The Journal of Surgical Research 145 (1): 142–149.CrossRefPubMed Corriere, M.A., et al. 2008. Endothelial Bmp4 is induced during arterial remodeling: Effects on smooth muscle cell migration and proliferation. The Journal of Surgical Research 145 (1): 142–149.CrossRefPubMed
24.
Zurück zum Zitat Bostrom, K., et al. 1993. Bone morphogenetic protein expression in human atherosclerotic lesions. The Journal of Clinical Investigation 91 (4): 1800–1809.CrossRefPubMedPubMedCentral Bostrom, K., et al. 1993. Bone morphogenetic protein expression in human atherosclerotic lesions. The Journal of Clinical Investigation 91 (4): 1800–1809.CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Bostrom, K., et al. 1995. Atherosclerotic calcification: Relation to developmental osteogenesis. The American Journal of Cardiology 75 (6): 88B–91B.CrossRefPubMed Bostrom, K., et al. 1995. Atherosclerotic calcification: Relation to developmental osteogenesis. The American Journal of Cardiology 75 (6): 88B–91B.CrossRefPubMed
26.
Zurück zum Zitat Bostrom, K.I., et al. 2011. Activation of vascular bone morphogenetic protein signaling in diabetes mellitus. Circulation Research 108 (4): 446–457.CrossRefPubMed Bostrom, K.I., et al. 2011. Activation of vascular bone morphogenetic protein signaling in diabetes mellitus. Circulation Research 108 (4): 446–457.CrossRefPubMed
27.
Zurück zum Zitat Demer, L.L., K.E. Watson, and K. Bostrom. 1994. Mechanism of calcification in atherosclerosis. Trends in Cardiovascular Medicine 4 (1): 45–49.CrossRefPubMed Demer, L.L., K.E. Watson, and K. Bostrom. 1994. Mechanism of calcification in atherosclerosis. Trends in Cardiovascular Medicine 4 (1): 45–49.CrossRefPubMed
28.
Zurück zum Zitat Csiszar, A., S. Lehoux, and Z. Ungvari. 2009. Hemodynamic forces, vascular oxidative stress, and regulation of BMP-2/4 expression. Antioxidants & Redox Signaling 11 (7): 1683–1697.CrossRef Csiszar, A., S. Lehoux, and Z. Ungvari. 2009. Hemodynamic forces, vascular oxidative stress, and regulation of BMP-2/4 expression. Antioxidants & Redox Signaling 11 (7): 1683–1697.CrossRef
29.
Zurück zum Zitat Bogen, S., et al. 1994. Monoclonal antibody to murine PECAM-1 (CD31) blocks acute inflammation in vivo. The Journal of Experimental Medicine 179 (3): 1059–1064.CrossRefPubMed Bogen, S., et al. 1994. Monoclonal antibody to murine PECAM-1 (CD31) blocks acute inflammation in vivo. The Journal of Experimental Medicine 179 (3): 1059–1064.CrossRefPubMed
30.
Zurück zum Zitat Helbing, T., et al. 2011. BMP activity controlled by BMPER regulates the proinflammatory phenotype of endothelium. Blood 118 (18): 5040–5049.CrossRefPubMed Helbing, T., et al. 2011. BMP activity controlled by BMPER regulates the proinflammatory phenotype of endothelium. Blood 118 (18): 5040–5049.CrossRefPubMed
31.
Zurück zum Zitat Heinke, J., et al. 2008. BMPER is an endothelial cell regulator and controls bone morphogenetic protein-4-dependent angiogenesis. Circulation Research 103 (8): 804–812.CrossRefPubMed Heinke, J., et al. 2008. BMPER is an endothelial cell regulator and controls bone morphogenetic protein-4-dependent angiogenesis. Circulation Research 103 (8): 804–812.CrossRefPubMed
32.
Zurück zum Zitat Helbing, T., et al. 2013. Inhibition of BMP activity protects epithelial barrier function in lung injury. The Journal of Pathology 231 (1): 105–116.CrossRefPubMed Helbing, T., et al. 2013. Inhibition of BMP activity protects epithelial barrier function in lung injury. The Journal of Pathology 231 (1): 105–116.CrossRefPubMed
33.
Zurück zum Zitat Winnier, G., et al. 1995. Bone morphogenetic protein-4 is required for mesoderm formation and patterning in the mouse. Genes & Development 9 (17): 2105–2116.CrossRef Winnier, G., et al. 1995. Bone morphogenetic protein-4 is required for mesoderm formation and patterning in the mouse. Genes & Development 9 (17): 2105–2116.CrossRef
35.
Zurück zum Zitat Fink, K., et al. 2015. Selenium prevents microparticle-induced endothelial inflammation in patients after cardiopulmonary resuscitation. Critical Care 19: 58.CrossRefPubMedPubMedCentral Fink, K., et al. 2015. Selenium prevents microparticle-induced endothelial inflammation in patients after cardiopulmonary resuscitation. Critical Care 19: 58.CrossRefPubMedPubMedCentral
36.
Zurück zum Zitat Grundmann, S., et al. 2012. Perturbation of the endothelial glycocalyx in post cardiac arrest syndrome. Resuscitation 83 (6): 715–720.CrossRefPubMed Grundmann, S., et al. 2012. Perturbation of the endothelial glycocalyx in post cardiac arrest syndrome. Resuscitation 83 (6): 715–720.CrossRefPubMed
37.
Zurück zum Zitat Bro-Jeppesen, J., et al. 2016. Endothelial activation/injury and associations with severity of post-cardiac arrest syndrome and mortality after out-of-hospital cardiac arrest. Resuscitation 107: 71–79.CrossRefPubMed Bro-Jeppesen, J., et al. 2016. Endothelial activation/injury and associations with severity of post-cardiac arrest syndrome and mortality after out-of-hospital cardiac arrest. Resuscitation 107: 71–79.CrossRefPubMed
38.
Zurück zum Zitat Valdimarsdottir, G., et al. 2002. Stimulation of Id1 expression by bone morphogenetic protein is sufficient and necessary for bone morphogenetic protein-induced activation of endothelial cells. Circulation 106 (17): 2263–2270.CrossRefPubMed Valdimarsdottir, G., et al. 2002. Stimulation of Id1 expression by bone morphogenetic protein is sufficient and necessary for bone morphogenetic protein-induced activation of endothelial cells. Circulation 106 (17): 2263–2270.CrossRefPubMed
39.
Zurück zum Zitat Vestweber, D. 2012. Relevance of endothelial junctions in leukocyte extravasation and vascular permeability. Annals of the New York Academy of Sciences 1257: 184–192.CrossRefPubMed Vestweber, D. 2012. Relevance of endothelial junctions in leukocyte extravasation and vascular permeability. Annals of the New York Academy of Sciences 1257: 184–192.CrossRefPubMed
40.
Zurück zum Zitat Ley, K., et al. 2007. Getting to the site of inflammation: The leukocyte adhesion cascade updated. Nature Reviews. Immunology 7 (9): 678–689.CrossRefPubMed Ley, K., et al. 2007. Getting to the site of inflammation: The leukocyte adhesion cascade updated. Nature Reviews. Immunology 7 (9): 678–689.CrossRefPubMed
41.
Zurück zum Zitat Csiszar, A., et al. 2006. Bone morphogenetic protein-2 induces proinflammatory endothelial phenotype. The American Journal of Pathology 168 (2): 629–638.CrossRefPubMedPubMedCentral Csiszar, A., et al. 2006. Bone morphogenetic protein-2 induces proinflammatory endothelial phenotype. The American Journal of Pathology 168 (2): 629–638.CrossRefPubMedPubMedCentral
42.
Zurück zum Zitat Csiszar, A., et al. 2005. Regulation of bone morphogenetic protein-2 expression in endothelial cells: Role of nuclear factor-kappaB activation by tumor necrosis factor-alpha, H2O2, and high intravascular pressure. Circulation 111 (18): 2364–2372.CrossRefPubMed Csiszar, A., et al. 2005. Regulation of bone morphogenetic protein-2 expression in endothelial cells: Role of nuclear factor-kappaB activation by tumor necrosis factor-alpha, H2O2, and high intravascular pressure. Circulation 111 (18): 2364–2372.CrossRefPubMed
43.
Zurück zum Zitat Wong, W.T., et al. 2010. Bone morphogenic protein-4 impairs endothelial function through oxidative stress-dependent cyclooxygenase-2 upregulation: Implications on hypertension. Circulation Research 107 (8): 984–991.CrossRefPubMed Wong, W.T., et al. 2010. Bone morphogenic protein-4 impairs endothelial function through oxidative stress-dependent cyclooxygenase-2 upregulation: Implications on hypertension. Circulation Research 107 (8): 984–991.CrossRefPubMed
44.
Zurück zum Zitat Derwall, M., et al. 2012. Inhibition of bone morphogenetic protein signaling reduces vascular calcification and atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology 32 (3): 613–622.CrossRefPubMed Derwall, M., et al. 2012. Inhibition of bone morphogenetic protein signaling reduces vascular calcification and atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology 32 (3): 613–622.CrossRefPubMed
45.
Zurück zum Zitat Yao, Y., et al. 2010. Inhibition of bone morphogenetic proteins protects against atherosclerosis and vascular calcification. Circulation Research 107 (4): 485–494.CrossRefPubMedPubMedCentral Yao, Y., et al. 2010. Inhibition of bone morphogenetic proteins protects against atherosclerosis and vascular calcification. Circulation Research 107 (4): 485–494.CrossRefPubMedPubMedCentral
46.
47.
Zurück zum Zitat Asmussen, A., et al. 2016. Inflammasome and toll-like receptor signaling in human monocytes after successful cardiopulmonary resuscitation. Critical Care 20 (1): 170.CrossRefPubMedPubMedCentral Asmussen, A., et al. 2016. Inflammasome and toll-like receptor signaling in human monocytes after successful cardiopulmonary resuscitation. Critical Care 20 (1): 170.CrossRefPubMedPubMedCentral
48.
Zurück zum Zitat Fink, K., et al. 2011. Circulating annexin V positive microparticles in patients after successful cardiopulmonary resuscitation. Critical Care 15 (5): R251.CrossRefPubMedPubMedCentral Fink, K., et al. 2011. Circulating annexin V positive microparticles in patients after successful cardiopulmonary resuscitation. Critical Care 15 (5): R251.CrossRefPubMedPubMedCentral
49.
Zurück zum Zitat Huet, O., et al. 2011. Postresuscitation syndrome: Potential role of hydroxyl radical-induced endothelial cell damage. Critical Care Medicine 39 (7): 1712–1720.CrossRefPubMed Huet, O., et al. 2011. Postresuscitation syndrome: Potential role of hydroxyl radical-induced endothelial cell damage. Critical Care Medicine 39 (7): 1712–1720.CrossRefPubMed
50.
Zurück zum Zitat Zhao, S., et al. 2015. Effects of oxygen concentrations on postresuscitation myocardial oxidative stress and myocardial function in a rat model of cardiopulmonary resuscitation. Critical Care Medicine 43 (12): e560–e566.CrossRefPubMed Zhao, S., et al. 2015. Effects of oxygen concentrations on postresuscitation myocardial oxidative stress and myocardial function in a rat model of cardiopulmonary resuscitation. Critical Care Medicine 43 (12): e560–e566.CrossRefPubMed
51.
Zurück zum Zitat Carmeliet, P., et al. 1999. Targeted deficiency or cytosolic truncation of the VE-cadherin gene in mice impairs VEGF-mediated endothelial survival and angiogenesis. Cell 98 (2): 147–157.CrossRefPubMed Carmeliet, P., et al. 1999. Targeted deficiency or cytosolic truncation of the VE-cadherin gene in mice impairs VEGF-mediated endothelial survival and angiogenesis. Cell 98 (2): 147–157.CrossRefPubMed
52.
Zurück zum Zitat Pachori, A.S., et al. 2010. Bone morphogenetic protein 4 mediates myocardial ischemic injury through JNK-dependent signaling pathway. Journal of Molecular and Cellular Cardiology 48 (6): 1255–1265.CrossRefPubMed Pachori, A.S., et al. 2010. Bone morphogenetic protein 4 mediates myocardial ischemic injury through JNK-dependent signaling pathway. Journal of Molecular and Cellular Cardiology 48 (6): 1255–1265.CrossRefPubMed
53.
Zurück zum Zitat Mungrue, I.N., et al. 2011. Abcc6 deficiency causes increased infarct size and apoptosis in a mouse cardiac ischemia–reperfusion model. Arteriosclerosis, Thrombosis, and Vascular Biology 31 (12): 2806–2812.CrossRefPubMedPubMedCentral Mungrue, I.N., et al. 2011. Abcc6 deficiency causes increased infarct size and apoptosis in a mouse cardiac ischemia–reperfusion model. Arteriosclerosis, Thrombosis, and Vascular Biology 31 (12): 2806–2812.CrossRefPubMedPubMedCentral
Metadaten
Titel
Endothelial BMP4 Regulates Leukocyte Diapedesis and Promotes Inflammation
verfasst von
Thomas Helbing
Linus Arnold
Gwendoline Wiltgen
Eva Hirschbihl
Valentin Gabelmann
Alexandra Hornstein
Jennifer S. Esser
Philipp Diehl
Sebastian Grundmann
Hans-Jörg Busch
Katrin Fink
Christoph Bode
Martin Moser
Publikationsdatum
28.07.2017
Verlag
Springer US
Erschienen in
Inflammation / Ausgabe 6/2017
Print ISSN: 0360-3997
Elektronische ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-017-0627-0

Kompaktes Leitlinien-Wissen Innere Medizin (Link öffnet in neuem Fenster)

Mit medbee Pocketcards schnell und sicher entscheiden.
Leitlinien-Wissen kostenlos und immer griffbereit auf ihrem Desktop, Handy oder Tablet.

Neu im Fachgebiet Innere Medizin

Verbände und Cremes gegen Dekubitus: „Wir wissen nicht, was sie bringen!“

Die Datenlage zur Wirksamkeit von Verbänden oder topischen Mitteln zur Prävention von Druckgeschwüren sei schlecht, so die Verfasser einer aktuellen Cochrane-Studie. Letztlich bleibe es unsicher, ob solche Maßnahmen den Betroffenen nutzen oder schaden.

Schützt das tägliche Glas Milch vor Darmkrebs?

Die Milch machts – sie bietet Frauen nach Daten einer großen Ernährungsanalyse den besten Darmkrebsschutz aller Lebensmittel, was am hohen Kalziumgehalt liegen dürfte. Am anderen Ende des Spektrums steht der Alkoholkonsum: Das Glas Wein am Abend ist eher ungünstig.

Vorsicht mit Glukokortikoiden bei Glomerulopathie

Auch niedrig dosierte Glukokortikoide zur Behandlung einer primären Glomerulopathie lassen offenbar die Infektionsgefahr steigen. In einer US-Studie hing das Risiko vor allem mit der kombinierten Anwendung von Immunsuppressiva zusammen.

KI-gestütztes Mammografiescreening überzeugt im Praxistest

Mit dem Einsatz künstlicher Intelligenz lässt sich die Detektionsrate im Mammografiescreening offenbar deutlich steigern. Mehr unnötige Zusatzuntersuchungen sind laut der Studie aus Deutschland nicht zu befürchten.

EKG Essentials: EKG befunden mit System (Link öffnet in neuem Fenster)

In diesem CME-Kurs können Sie Ihr Wissen zur EKG-Befundung anhand von zwölf Video-Tutorials auffrischen und 10 CME-Punkte sammeln.
Praxisnah, relevant und mit vielen Tipps & Tricks vom Profi.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.